Healthcare Spending & Regulations: As a medical device company, Avanos Medical is significantly influenced by healthcare spending trends, evolving government regulations, and reimbursement policies, such as the NOPAIN Act, which can directly impact product adoption and revenue. The recent US job growth may stabilize healthcare access but regulatory changes remain a constant factor.

Global Supply Chain Disruptions & Tariffs: Avanos Medical has acknowledged tariff impacts on its supply chain, leading to strategic shifts like relocating syringe manufacturing from China. Ongoing geopolitical tensions, particularly the Middle East conflict, could further disrupt global supply chains, increasing manufacturing and logistics costs.

Inflationary Pressures & Economic Growth: Rising oil prices due to the Middle East conflict contribute to inflationary pressures, which can increase Avanos Medical's operational costs. The IMF's downgraded global growth forecasts suggest a tighter economic environment, potentially impacting healthcare budgets and demand for certain medical devices, despite the essential nature of many of Avanos' products.